Investors / filer profile

MPM BioVentures 2014, L.P.

active in 2 companies

Pro
Bought: Pro
Sold: 40
Filings: 2
Companies: 2026-09-09
Last filed

EDGAR · CIK 0001609492 ↗

Track record

How each disclosed position did against the S&P ~6 months later

No positions we can measure against the market yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$0.0000 bought · −$5.82M sold

All filings on record

Every Form 4 transaction we track for this filer


TRDAEntrada Therapeutics, Inc.	Sell $205.6K · 28,837 sh	2026-09-09	—
TRDAEntrada Therapeutics, Inc.	Sell $1.43M · 192,500 sh	2026-09-08	—
TRDAEntrada Therapeutics, Inc.	Sell $273.7K · 38,500 sh	2026-09-04	—
TRDAEntrada Therapeutics, Inc.	Sell $231.3K · 32,263 sh	2026-09-03	—
TRDAEntrada Therapeutics, Inc.	Sell $180.7K · 25,131 sh	2026-09-02	—
TRDAEntrada Therapeutics, Inc.	Sell $205.4K · 29,088 sh	2026-09-01	—
TRDAEntrada Therapeutics, Inc.	Sell $309.4K · 44,259 sh	2026-08-31	—
TRDAEntrada Therapeutics, Inc.	Sell $26.2K · 3,733 sh	2026-08-28	—
TRDAEntrada Therapeutics, Inc.	Sell $280.2K · 38,922 sh	2026-08-27	—
TRDAEntrada Therapeutics, Inc.	Sell $102.9K · 14,569 sh	2026-08-26	—

TRDASell

2026-09-09 · Entrada Therapeutics, Inc.

$205.6K

—

TRDASell

2026-09-08 · Entrada Therapeutics, Inc.

$1.43M

—

TRDASell

2026-09-04 · Entrada Therapeutics, Inc.

$273.7K

—

TRDASell

2026-09-03 · Entrada Therapeutics, Inc.

$231.3K

—

TRDASell

2026-09-02 · Entrada Therapeutics, Inc.

$180.7K

—

TRDASell

2026-09-01 · Entrada Therapeutics, Inc.

$205.4K

—

TRDASell

2026-08-31 · Entrada Therapeutics, Inc.

$309.4K

—

TRDASell

2026-08-28 · Entrada Therapeutics, Inc.

$26.2K

—

TRDASell

2026-08-27 · Entrada Therapeutics, Inc.

$280.2K

—

TRDASell

2026-08-26 · Entrada Therapeutics, Inc.

$102.9K

—

Newest 10 of 40 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.